Michael J. Farrell
Director; Director, Chairman and CEO · 4 filings · Latest: Jun 8, 2026
RESMED INC
ZIMMER BIOMET HOLDINGS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RMD | Michael J. Farrell | Director, Chairman and CEO | Jun 8, 2026 | Sale | $193.96 | 4,991 | $968.1K | 466,256 | |
RMD | Michael J. Farrell | Director, Chairman and CEO | Jun 8, 2026 | Option Exercise | $146.34 | 4,991 | $730.4K | 471,214 | |
RMD | Michael J. Farrell | Director, Chairman and CEO | May 7, 2026 | Sale | $207.82 | 4,991 | $1.0M | 466,223 | |
RMD | Michael J. Farrell | Director, Chairman and CEO | May 7, 2026 | Option Exercise | $146.34 | 4,991 | $730.4K | 471,214 | |
RMD | Michael J. Farrell | Director, Chairman and CEO | Mar 9, 2026 | Sale | $251.03 | 4,991 | $1.3M | 466,223 | |
RMD | Michael J. Farrell | Director, Chairman and CEO | Mar 9, 2026 | Option Exercise | $146.34 | 4,991 | $730.4K | 471,214 |